Tran Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Tran Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-41,585	Closed	-$2.2M	–	109
2014 Q1	$2.2M	Sell	41,585 -64,307	-61%	-$2.97M	0.04%	76
2013 Q4	$4.24M	Sell	105,892 -12,822	-11%	-$505K	0.07%	60
2013 Q3	$4.49M	Buy	118,714 +3,774	+3%	+$147K	0.09%	53
2013 Q2	$4.51M	Buy	+114,940	New	+$4.48M	0.1%	47

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Tran Capital Management's TEVA Position: Q2 2014 in Review

Tran Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2014, closing a stake of 41,585 shares — an estimated $2.2M sold.

Tran Capital Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $4.51M in Q2 2013. 780 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

Tran Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2014 after selling out during the quarter.
Tran Capital Management sold 41,585 Teva Pharmaceutical Industries Limited shares in Q2 2014, an estimated $2.2M.
Tran Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 4 quarters.
Tran Capital Management's Teva Pharmaceutical Industries Limited position peaked at $4.51M in Q2 2013.
780 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2014.

Based on Tran Capital Management's 13F filing for Q2 2014, filed 29 Jul 2014.